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Audit of IV iron sucrose (Venofer®) usage in Groote 
Schuur Hospital’s Gastrointestinal Unit 
Y Awuku, C A Viljoen, M Setshedi, G Watermeyer, 
S R Thomson
Gastrointestal Unit, Division of Gastroenterology, Groote Schuur Hospital and 
University of Cape Town
Introduction. Intravenous (IV) iron sucrose (Venofer®) therapy has 
merit in the management of iron deficiency anaemia in 2 categories 
of gastrointestinal (GI) patients: those with inflammatory bowel 
disease (IBD) and those with obscure or recurrent GI bleeds. We 
wished to audit the effectiveness of this practice in our GI patients.
Methods and materials. This was a retrospective descriptive study 
of 67 iron-deficiency anaemia patients seen at the GI clinic who 
received IV iron therapy as day cases. Over a 6-month period results 
were obtained of their full blood counts and iron studies (n=49) at 
baseline and post IV iron (Venofer®). Those that received a blood 
transfusion were excluded.
Results. Participants were predominantly female (69.4%) and 
32.6% had IBD. Mean age was 56.2±19.6 years and mean quantity 
of IV iron given was 885 mg (±355 mg) (approximately 3 infusions). 
No adverse effects were documented. Mean baseline haemoglobin 
(Hb) was 10.0 g/dl, with no differences between the IBD and non-
IBD groups. However, post-IV infusion, the mean Hb increased by 
1.2 g/dl. Mean baseline iron was lower in IBD patients (5.89 mmol/l) 
than in non-IBD patients (7.8 mmol/l). Post-infusion mean iron for 
the entire cohort was higher by 6.3 units (11.5 in IBD and 14.4 in 
non-IBD patients). 
Conclusion. IV iron therapy is safe and shows good response in 
Hb and iron levels in IBD and non-IBD patients, but has a more 
pronounced effect on iron levels in the latter. These data provide a 
benchmark for comparison with other therapies in these categories 
of our GI patient population. 
Key words. Anaemia; iron deficiency anaemia; inflammatory bowel 
disease (IBD); intravenous iron.
Successful use of endoscopic SEMS to palliate malignant 
gastric outlet obstruction
S Burmeister, J E J Krige, J M Shaw, S R Thomson, G Chinnery, 
M Bernon, P C Bornman
Surgical Gastroenterology Unit, Groote Schuur Hospital, and Department of Surgery, 
Faculty of Health Sciences, University of Cape Town 
Background. Enteral stenting has evolved over the past decade 
as an alternative to surgical bypass in the palliation of malignant 
gastric outlet obstruction. In particular, it offers a less invasive 
option in the management of patients who are often at significant 
risk for peri-procedural morbidity and mortality. This single-centre 
prospective study evaluated the success of enteral stenting for the 
relief of advanced malignant gastroduodenal obstruction.
Methods. Between January 2006 and April 2012, 127 patients (74 
men, 53 women; mean age 60.1 years) with clinical, radiological 
and endoscopic gastric outlet obstruction as a result of irresectable 
malignancy due to local extent, regional or distant metastatic 
disease or patient choice, underwent endoscopic placement of a self-
expanding metal stent (SEMS) to relieve symptoms. 
Results. The technical success rate of endoscopic SEMS placement 
was 96%, allowing patients to be discharged at a mean of 4 days 
(range 1 - 23) post stent placement. Fourteen patients (11%) required 
placement of a second stent due to either a long distal stricture or 
early technical failure (n=8), or as a result of delayed re-obstruction 
from tumour ingrowth (n=6). Complications included bleeding 
(n=2), perforation (n=1), early blockage from a food bolus (n=1), 
stent migration (n=1) and re-obstruction from stent shortening/
deformation (n=1). One patient died following failed stent placement 
with tumour perforation.
Conclusion. Endoscopic SEMS placement can be safely used 
to relieve non-resectable malignant gastroduodenal obstruction, 
minimising hospital stay and peri-procedural morbidity. Technical 
factors influence its early success rate while secondary stenting is 
effective in managing subsequent tumour ingrowth.
Temporary placement of covered SEMS for benign 
gastroduodenal pathology
G E Chinnery, J E J Krige, M M Bernon, S Al-Harethi, 
M E C van Wyk, P C Bornman
Groote Schuur Hospital, Cape Town
Background. Palliation of malignant gastroduodenal obstruction 
by self-expanding metal stent (SEMS) placement is the accepted 
treatment of choice. While indications for SEMS placement have 
expanded, the application for benign gastroduodenal pathology 
remains controversial. We evaluated SEMS efficacy in patients with 
benign gastric outlet obstruction (GOO) and duodenal fistulation.
Methods. We analysed a prospective database documenting patients 
with temporary placement of retrievable covered SEMS for benign 
gastroduodenal pathology.  Technical and clinical successes, as well as 
short- and long-term complications were evaluated.
Results. Eleven patients (6 men, 5 women) of median age 56.6 years 
(range 35 - 76), had endoscopic placement of a covered retrievable 
duodenal SEMS for GOO due to peptic ulcer disease (n=6), extrinsic 
compression (n=3), pyloric stricture following repair of a perforated 
peptic ulcer (n=1) and high-output traumatic duodenal fistula (n=1). 
Indications included significant patient comorbidity, recent surgery 
and patient preference. Ten stents (91%) were placed successfully; 
1 misplaced stent was replaced within 48 hours. Hemoclips were 
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applied to prevent migration. Early proximal stent migration in 1 
patient required replacement after 4 days. Planned retrieval of stents 
was at 6 weeks. Late migration occurred in 2 patients. One stent was 
not removable. Four patients (36%) required surgical intervention 
for recurrent GOO within 4 - 6 weeks. Seven patients (63%) remain 
symptom-free at 2 - 18 months after stent removal.
Conclusion. While surgery remains the standard of care for benign 
GOO, temporary duodenal stenting may avoid surgery or improve 
nutritional status and comorbidity before surgical intervention in 
selected patients.
Are current ERCP training requirements adequate to 
ensure competency in interventional endoscopy?
G E Chinnery, J E J Krige, P C Bornman, M M Bernon, H P Essel, 
S Al-Harethi, E Deetlefs, N Rajabally, S Burmeister, S R Thomson
Groote Schuur Hospital
Background. Endoscopic retrograde cholangiopancreatography 
(ERCP) is technically the most difficult endoscopic procedure 
to master, with higher failure and complication rates than other 
endoscopic interventions. Recommendations for the number of 
procedures to be performed before achieving competence range 
from 35 to 200. Traditionally, an 80% bile duct cannulation rate on 
completion of ERCP training is the desired aim. In an era where the 
majority of ERCPs performed are therapeutic, is this still an adequate 
form of assessment?
Methods. An ERCP database was retrospectively reviewed 
to identify all procedures performed by trainees. Eight surgical 
and medical gastroenterology trainees completed their 2-year 
subspecialty training between 2006 and 2012 at Groote Schuur 
Hospital. No trainee had prior ERCP experience. Each trainee’s 
initial 120 supervised ERCPs were retrospectively reviewed, with 
division into sequential chronological groups of 30. Comparisons 
between assisted and unassisted completed ERCPs within the 
trainees’ subgroups were made. Completing an ERCP entailed both 
deep biliary cannulation and completion of the required therapeutic 
intervention of sphincterotomy, stenting or stone extraction unaided.
Results. Six trainees showed a definitive trend towards improvement 
over the 4 quarters, but only 3 had an ERCP completion rate >75% by 
the final quarter. The average trainee unaided completion rate after 
120 ERCPs was 67%.
Conclusion. Due to the complexity of interventional endoscopy, 
accreditation in performing ERCPs should include steady progress 
and successful completion rates, rather than an evaluation of biliary 
cannulation only. A prospective study is needed to redefine the 
criteria of competency in interventional ERCPs.
Aetiological discrimination of the causes of biliary 
obstruction in the presence of gallbladder stones
L Ferndale, S R Thomson
Introduction. Malignant bile duct obstruction and choledocholithiasis 
are the most common aetiologies of biliary obstruction. Trans-
abdominal ultrasound can identify gallstones with a high sensitivity 
but it is highly operator-dependent and does not accurately detect bile 
duct stones. We assessed the utility of other clinical and biochemical 
markers in predicting the actual cause of the biliary obstruction in 
patients with gallbladder stones on trans-abdominal ultrasound.
Methods. We performed a retrospective analysis of prospectively 
collected endoscopic retrograde cholangiopancreaticogram 
(ERCP) data. Data on patients undergoing ERCP for suspected 
choledocholithiasis over a 2-year period were reviewed. Data collected 
included demographics, presence of comorbidities and laboratory 
investigations such as liver and renal function and haematology tests.
Results. A total of 162 patients were identified; 40 were excluded 
because of failed cannulation or a normal cholangiogram. Of the 122 
patients studied, 82 had confirmed bile duct stones (group 1) and 40 
had alternative diagnoses (group 2). Mean patient age in group 1 was 
50.7 years v. 58.2 years in group 2 (p<0.05). The female to male ratio 
was higher in group 1 than in group 2. Higher serum bilirubin and 
liver enzymes and lower albumin levels also significantly predicted 
the finding of alternative diagnoses in these patients. 
Conclusion. Male gender, higher serum bilirubin and liver 
enzymes, and lower albumin levels are predictors of an alternative 
diagnosis to choledocholithiasis in patients with gallbladder stones. 
Accurate identification of the one-third of patients with no ductal 
stones would allow appropriate further imaging prior to an appraisal 
of ERCP need. 
SEMS insertion: Fluoroscopy v. pure endoscopy – a cost 
comparison
M Govender, D Clarke
Greys Hospital and Department of Health, KwaZulu-Natal 
Background. Self-expanding metal stenting (SEMS) is used for 
palliation of dysphagia in oesophageal cancer. In most centres it is 
performed under fluoroscopic guidance. Limited access to fluoroscopy 
at our institution led us to develop a pure endoscopic technique. We 
undertook a cost comparison of both approaches.
Patients and methods. We performed a prospective analysis of 
patients stented at Greys Hospital utilising endoscopy alone compared 
with patients stented at IALCH in Durban where fluoroscopy is 
routinely used. We observed and documented 20 procedures at 
each centre. Average costing was estimated using protocols from 
the Revenue department and private practitioners. Individual cost 
drivers include use of the fluoroscopy suite, use of contrast, screening 
time and overall procedure time. 
Results. The average additional cost of utilising fluoroscopic 
guidance for SEMS insertion is approximately R2 065.00 per patient. 
The average total procedure time of the pure endoscopic technique 
was 5 min (range 4 - 11 min) v. 17.5 min (range 5 - 24 min) for 
routine fluoroscopy. The use of screening also exposed the operator 
to an estimated 1.05 mGy of radiation per procedure.
Conclusion. In a resource-limited setting with a high burden 
of inoperable oesophageal cancer, time and cost are 2 significant 
variables. This simple analysis confirms that the pure endoscopic 
technique of SEMS insertion is more cost-effective and time-efficient 
than routine fluoroscopy.
Outcome in decompensated alcoholic cirrhosis patients 
with acute variceal bleeding
M I Hampton, J E J Krige, U K Kotze, S Burmeister, M M Bernon, 
G E Chinnery, S Alherthi, S Hofmeyr
Department of Health, Western Cape
Objectives. Variceal bleeding (VB) is the leading cause of death in 
cirrhotic patients with portal hypertension and oesophageal varices. 
This prospective single-centre study evaluated the efficacy of 
emergency endoscopic intervention in the control of acute VB and 
the prevention of rebleeding and death during the index hospital 
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admission in a large cohort of consecutively treated alcoholic 
cirrhotic patients after the first variceal bleed.
Methods. From January 1984 to August 2011, 448 alcoholic 
cirrhotic patients (349 men, 99 women; median age 50 years) with VB 
underwent 805 endoscopic treatments (556 emergency, 249 elective) 
during their index hospital admission. Injection sclerotherapy was 
used to control bleeding until 1990 and subsequently variceal 
banding was used. Child-Pugh (C-P) class and score, endoscopic 
control of initial bleeding, variceal rebleeding and survival after the 
first hospital admission were recorded. 
Results. Endoscopic intervention alone controlled VB in 394 
patients (87.9%), while 54 patients also required balloon tamponade. 
Fifteen patients rebled within 24 hours and 61 rebled after 24 hours 
(N=76; 17%). Ninety-three patients (20.8%) died in hospital. No C-P 
class A patients died, while 16 (8.9%) C-P class B and 77 (35.8%) C-P 
class C patients died. Mortality increased exponentially as the C-P 
score increased, reaching 80% with a C-P score >13.
Conclusion. Despite initial endoscopic control of variceal 
haemorrhage, 17% of patients (1/6) rebled during the first hospital 
admission. The survival rate of 79.2% was influenced by the severity 
of liver failure, with most deaths occurring in C-P grade C patients 
in this study.
Repairing major laparoscopic bile duct injuries: What 
does it cost?
S Hofmeyr, J E J Krige, P C Bornman
Surgical Gastroenterology Unit, Groote Schuur and UCT Private Academic Hospital 
and Department of Surgery, Faculty of Health Sciences, University of Cape Town
Background. A major bile duct injury is an infrequent but potentially 
life-threatening complication after laparoscopic cholecystectomy. 
Few data exist about the financial implications of duct repair. 
We aimed to calculate the costs of operative repair in a cohort of 
patients who underwent bile duct reconstruction after major ductal 
injury.
Methods. A prospective database was reviewed to identify all 
patients referred to the University of Cape Town Private Academic 
Hospital between 2002 and 2011 for assessment and repair of 
major laparoscopic bile duct injuries. The detailed clinical records 
and billing information were evaluated to determine all costs from 
admission to discharge. Total costs for each patient were adjusted for 
inflation between year of repair and 2012. 
Results. Thirty-four patients, including 25 female and 9 male of 
median age 49 years (range 32 - 71) with a major bile duct injury, 
were referred for management after a median of 21 days (range 1 - 
280) following initial surgery. Patients were admitted to hospital for 
a median of 13.5 days (range 6 - 52 days). The mean cost of repair 
was R182 400 (range R70 112 - R395 515). Contributors to cost 
were hospital bed costs (27.4%), theatre costs (27.2%), radiology 
(16.1%), specialist fees (9.9%), consumables (8.1%), pharmacy (5.2%), 
endoscopy (3.3%) and laboratory costs (2.9%).
Conclusions. The cost of repair of a major laparoscopic bile duct 
injury is substantial due to prolonged admission to hospital, complex 
surgical intervention and intensive imaging requirements.
Efficacy of single-agent injection therapy in achieving 
haemostasis in patients with acutely bleeding peptic 
ulcers
F Jacobsohn, J E J Krige, D A Levin, J M Shaw, D Epstein, 
S R Thomson, P C Bornman
Surgical and Medical Gastroenterology Units, Groote Schuur Hospital, Departments of 
Surgery and Medicine, University of Cape Town Health Sciences Faculty, Cape Town
Background. Endoscopic therapy is the standard of care in patients 
with bleeding peptic ulcer disease. This study was undertaken to 
determine the efficacy of injection therapy, using adrenaline/saline 
solution (ASS) alone, with regards to the rate of rebleeding, need for 
surgery and death. 
Methods. Over a 21-month period, data were prospectively collected 
regarding patients presenting to Groote Schuur Hospital with acute 
peptic ulcer bleeding and treated with endoscopic therapy. The rate 
of rebleeding, surgical or other intervention and mortality were 
recorded and analysed. In addition, demographic data, comorbidity, 
non-steroidal and aspirin use, length of hospital stay, transfusion 
requirements, endoscopic findings, Rockall score and aetiology of 
bleeding, were recorded. 
Results. Eighty patients (median age 54 years, range 22 - 91) were 
included; 51/80 (63.8%) were male; 61/80 (76.3%) had successful 
primary haemostasis; 19 (23.7%) patients failed primary haemostasis 
and required either repeat endoscopy or surgical intervention; 
17/80 (21.3%) underwent second endoscopic therapy. Overall, 6/80 
(7.5%) required surgical intervention after failure of primary or 
secondary endotherapy. One patient underwent embolisation of the 
gastroduodenal artery. The mortality rate was 11.4% (9/80 patients); 
8 died due to associated comorbidity (malignancy, IHD, CRF, CVA); 
1 death was due to bleeding and miliary TB. 
Conclusion. Single-agent endoscopic intervention controlled 
bleeding in 76% of patients with acute peptic ulcer bleeding. In those 
who rebled, second endoscopic management controlled bleeding 
in 70%. Surgery or embolisation was required in 8.8% of patients. 
Although overall mortality was 11%, medical comorbidity, rather 
than acute bleeding, accounted for 89% of deaths.
Correlation between HFE gene mutations and ALT levels 
may increase cardiovascular disease risk in patients with 
non-alcoholic steatohepatitis NASH
C Kruger, M Kotze
Background. Both non-alcoholic fatty liver disease (NAFLD) 
and alanine transaminase (ALT) are independent risk factors for 
cardiovascular mortality. Non-alcoholic steatohepatitis (NASH), the 
histologically advanced form of NAFLD, is an independent risk factor 
for cardiovascular disease (CVD) morbidity and mortality.
Aim. Key genes involved in metabolic pathways relating to 
atherogenic dyslipidaemia, chronic inflammation, hypercoagulation 
and iron dysregulation implicated in insulin resistance as a common 
feature of NAFLD, were studied to identify a genetic subgroup at 
increased risk of cardiovascular mortality compared with controls. 
Methods. A total of 178 patients diagnosed with NAFLD and 
75 controls were studied using direct sequencing and real-time 
polymerase chain reaction (PCR) for mutation detection. The 
analyses included eight deleterious low-penetrance mutations in 5 
genes: APOE2, APOE4, F2-20210, FV-Leiden, HFE-C282Y, HFE-
H63D, MTHFR-677 and MTHFR-1298. Relevant biochemical 
determinations, including ALT level, were performed for all subjects 
and compared using appropriate statistical analyses.
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Results. There was no statistically significant difference in genotype 
distribution for individual mutations between the NAFLD v. control 
subjects. However, in a sub-analysis a significant increase (p=0.04) in 
ALT levels was detected in NASH patients found to be heterozygous 
or homozygous for the HFE-C282Y and HFE-H63D mutations 
(n=10), compared with mutation-negative patients (n=34). 
Conclusion. We could not implicate the genes selected from known 
pathways in increasing CVD risk in NAFLD patients. However, 
the close association between known risk factors for increased 
CVD morbidity and mortality, namely raised ALT, NASH and 
HFE mutations, was confirmed. Subjects with HFE gene mutations 
have been found to have an increased CVD risk. The role of such 
mutations in increasing CVD risk in NASH patients needs to be 
investigated.
A pooled analysis of perineal hernia repair after 
abdominoperineal resection 
M Mjoli1, D Sloothaak2, C Buskens2, W Bemelman2, P Tanis2
1. Department of Surgery, Pietermaritzburg Hospital Complex and University of 
KwaZulu-Natal, Durban; 2. Department of Surgery, Academic Medical Centre, 
University of Amsterdam, The Netherlands
Aim. The purpose of this study was to determine the treatment 
characteristics and clinical outcomes of patients with perineal hernia 
after abdominoperineal resection (APR).
Method. A systematic literature search revealed 40 individually 
documented patients (published between 1944 and 2010). Three 
patients treated at the Academic Medical Centre in the Netherlands 
were also included. Patient characteristics, repair type and outcome 
were recorded and a pooled analysis of the 43 patients was performed.
Results. Pooled analysis revealed a median time interval of 8 
months between APR and surgical repair of perineal hernia. The 
surgical approaches were perineal in 22 patients, open abdominal in 
11, open abdominoperineal in 3, laparoscopic in 5 and laparoscopic-
perineal in 2 patients. A primary recurrence was documented in 13 
patients and a second recurrence in 3. The recurrence rate was 5/25 
for synthetic or biological mesh, 6/12 for primary closure and 2/6 for 
the remaining techniques. Recurrent perineal hernia was repaired 
using a synthetic or biological mesh (N=6), primary closure (N=5) or 
a muscle flap (gluteus or gracilis) (N=4).
Conclusion. From these limited and biased data based on published 
case descriptions, it appears that the recurrence rate of primary 
perineal hernia repair after APR is lower with the use of a mesh or 
other assisted closure in comparison with primary suture repair.
Note. This work was accepted for publication in Colorectal Disease: 
Mjoli M, et al. Colorectal Dis 2012;14(7):e400-e406 (online 8 June 
2012). 
A review of patients with chronic hepatitis C treated with 
pegylated interferon and ribavirin at a central referral 
hospital in Durban
V Naidoo, K A Newton
University of KwaZulu-Natal
Introduction and objectives. Local experience in the treatment of 
hepatitis C virus (HCV) is relatively limited, primarily due to fewer 
HCV patients and limited resources compared with the developed 
world. Since 2006 the Gastroenterology Department at Inkosi Albert 
Luthuli Central Hospital (IALCH) has had access to pegylated 
interferon and ribavirin to treat suitable HCV patients. We describe 
our early experience with HCV treatment in a low-prevalence region, 
with particular reference to treatment outcomes.
Methods. A retrospective audit was performed of HCV patients 
who received treatment from the Gastroenterology Department 
between 2006 and 2011. Data were obtained from standard data 
sheets used to aid patient management during treatment and patient 
records. Demographics, genotype, early virological response (EVR) 
and sustained virological response (SVR) were recorded. Simple 
descriptive statistics were used to analyse data.
Results. A total of 7 patients received treatment. One patient 
who had genotype-1 infection, a high baseline viral load and type 
2 diabetes mellitus, did not achieve an EVR and treatment was 
stopped after 16 weeks. One patient had genotype-1 infection, 3 had 
genotype-3, 1 had genotype-4 and 2 had genotype-5 infection. Five 
out of the 6 patients who completed a standard course of treatment 
achieved SVR (83%). Both patients with genotype-5 infection were 
treated for 48 weeks and achieved SVR.
Conclusion. Despite the small number of patients treated, it is 
rewarding to document that a significant number who completed 
treatment achieved SVR which equates to a cure. 
Re-activated Wnt signalling is crucial in hepatocellular 
carcinoma pathogenesis in double-transgenic mice that 
constitutively over-express HBx and IRS-1 in the liver
M Setshedi
University of Cape Town
Background. Hepatocellular carcinoma (HCC) is associated Wnt/β-
catenin with aberrant growth factor signalling. Both the insulin/
insulin-like growth factor (IGF) and Wnt/β-catenin have been 
implicated in the pathogenesis of HCC. To date there are no 
therapeutic molecules targeting this pathway; therefore, identifying 
the target genes of Wnt signalling remains critical for understanding 
β-catenin-mediated carcinogenesis.
Aim. The purpose of this work was to characterise the gene 
expression patterns of Wnt/β-catenin signalling in a double-
transgenic mouse model of HCC.
Methods. We analysed liver tissue from mice sacrificed at 
various time points (n=12 per time point) by quantitative real-time 
polymerase chain reaction (qRT-PCR) using a PCR array panel. 
Wildtype mice were used as controls.
Results. Tumours developed only in male mice generally after 15 - 
18 months. The majority of Wnt ligands, receptors and downstream 
targets were upregulated in mice without tumours at early time 
points. However, some genes including Wnt-1, -2, -3, -4, -6, -7b, -11 
and Fzd-8, -2, -3 and Fzd-b were also upregulated in HCC (occurring 
at later time points), suggesting re-activation of Wnt signalling in 
HCC. Specifically Wnt-5b and -7b were significantly upregulated in 
mice with tumours, suggesting they may be key regulators in hepatitis 
B virus (HBV)-related HCC. 
Conclusions. Our study identified several candidate genes of Wnt 
signalling, particularly Wnt5b and -7b that are dysregulated and 
in combination with 1 or more co-factors, i.e. HBx and/or insulin 
receptor substrate-1 (IRS-1) are carcinogenic in mouse HCC. These 
genes may serve as useful potential therapeutic targets for the 
treatment of HCC.
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IL28B polymorphisms are not predictive in South 
African patients infected with hepatitis C genotype 5
M Sonderup1, W Abuelhassan2, C W Spearman1
1. Department of Medicine and Division of Hepatology, Groote Schuur Hospital 
and University of Cape Town; 2. Department of Gastroenterology, Chris Hani 
Baragwanath Academic Hospital, Soweto
Background. Hepatitis C virus (HCV)-genotype 5 (G5), endemic 
in southern Africa, is often neglected in major trials. While single 
nucleotide polymorphisms (SNPs) of the interleukin-28B gene 
(IL28B) on chromosome 19 have been associated with treatment 
response in genotypes 1 - 4, scant data and only in white patients, 
suggest no predictive value of IL28B in HCV-G5. No such data exist 
for South African patients or those of different ethnicities.
Methods. Genomic DNA was obtained from peripheral blood 
mononuclear cells (PBMCs) in a cohort of G5 patients and analysed 
for the rs12979860 SNP near IL28B. Treated patients in the cohort had 
received peg-interferon-α-2a and weight-based ribavirin. Genotypes 
were analysed for their association with treatment response. 
Results. In a cohort of 35 patients, 28 who had completed 
treatment were evaluated. Of these, 57% (16) were male, mean age 
was 52.5±12.1 years in men and 54.8±10.5 years in women. Median 
alanine transaminase (ALT) was 66 IU/ml (range 14 - 215), fibrosis 
score (F) was 2 (n=22) and baseline HCV ribonucleic acid (RNA) was 
6.05 (3.6 - 7.4) log IU/ml. F≥3 was present in 27% of patients. Median 
body weight was 80 kg (range 53 - 130). Overall, the frequencies of 
the rs12979860-IL28B genotype were CC=25%, TC=43%, TT=32% 
with the distribution, respectively; in blacks (n=14) being CC=14%, 
TC=36%, TT=50% and in whites (n=11) being CC=36%, TC=54%, 
TT=9%. Genotypes were equally distributed in those of mixed 
ancestry. Overall, a rapid viral response (RVR), early viral response 
(EVR), end-of-treatment response (ETR) and sustained viral response 
(SVR) rate was seen in 60% (17), 100%, 96% (27) and 84% (22) of 
patients, respectively. The odds ratios (95% confidence interval) for 
an RVR and SVR for genotype CC v. non-CC (1.9, range 0.3 - 11.9, 
p=0.5; 0.6, range 0.1 - 4.2, p=0.59), TT v. non-TT (0.4, range 0.1 - 1.9, 
p=0.37; 0.9, range 0.1 - 6.4, p=0.94) and TC v. non-TC (1.6, range 0.3 
- 7.4, p=0.57; 1.7, 0.3 - 11.1, p=0.59) were not predictive of response to 
treatment. In addition, ethnicity viz. black v. white, did not influence 
the probability of achieving an RVR (p=0.88) or SVR (p=0.35).
Conclusions. In this albeit modest cohort of treated HCV-G5 
patients of different ethnicities, IL28B polymorphisms did not 
significantly predict RVR or SVR. This may reflect that the viral 
kinetics of HCV-G5 more closely resemble -G2 and -G3, although a 
larger study is required to confirm this finding.
Pneumatic balloon dilatation v. laparoscopic Heller’s 
myotomy for achalasia: A prospective evaluation
P C Bornman, R Baigree, S Botha, S R Thomson, 
G Watermeyer, D Levin
Gastrointestinal Unit, Groote Schuur Hospital and University of Cape Town
Background. Laparoscopic Heller’s myotomy (LHM) and pneumatic 
balloon dilatation (PBD) are widely used in the management of 
achalasia. Consensus among experts on the superior treatment 
modality is lacking.
Methods. Achalasia patients who presented between 1999 and 
2007 were assessed for entry into a randomised controlled trial 
between LHM and PBD. Clinical data were collected prospectively, 
including weight loss, dysphagia, chest pain, regurgitation, heartburn 
and dysphagia score. Due to patient preference, only one-third of 
patients were randomised to either therapy. Both randomised and non-
randomised patients were evaluated. The primary outcome of success 
was defined as relief of dysphagia without the need for an alternative 
intervention. Complication rate was evaluated as a secondary outcome. 
Results. Twenty-nine of the 45 patients (64%) had PBD and 16 
(36%) had LHM. There was no difference between the 2 treatment 
groups with regards to baseline characteristics. The median follow-up 
period was 30 months (range 1 - 96 months). The success rate in LHM 
patients was 81% (13/16) v. 69% (20/29) for PBD. This trend was not 
significant. None of the clinical parameters evaluated were predictive 
of failure risk. The complication rate was confined to the LHM 11% 
(5/45) and included 2 perforations in the LHM arm, recognised and 
treated during the initial procedure and a peptic stricture.
Conclusion. Although there is a bias in favour of LHM, the 2 
treatment modalities are comparable in efficacy. Interventions were 
safe with no mortality.
Management of hepatitis C virus infection at Chris Hani 
Baragwanath Academic Hospital, Johannesburg 
W Abuelhassan, R Ally
Gastroenterology Department, Chris Hani Baragwanath Academic Hospital, Soweto
Introduction. Hepatitis C virus (HCV) is a leading cause of chronic 
liver disease, cirrhosis and hepatocellular carcinoma. South Africa 
(SA) has a low prevalence of HCV infection (0.16 - 1.8%).  
Objectives. To report our experience in the management of HCV 
infection at Chris Hani Baragwanath Academic Hospital (CHBAH).
Methods. Consecutive patients attending CHBAH hepatitis C 
clinic between 2007 and April 2012 were considered for enrolment. 
Demographics, clinical data, HCV genotype and treatment response 
were analysed. Patients were treated with peginterferon-α-2a and 
ribavirin according to SA guidelines.
Results. Fifty-eight patients (30 male, 28 female; mean age 52.4 
years) were enrolled. The majority were blacks (46; 79.3%), followed 
by Asians (7; 12.1%), and whites (5; 8.6%). The predominant HCV 
genotype was 5a (26; 44.8%), all occurring in black patients. Among 
the remaining 32 patients, 11 had genotype 1; 9 had genotype 3 
(mostly Asians); 6 had genotype 4 (3 from the DRC); and 3 patients 
had 2 genotypes (1b and 4a; 1b and 5a; 1 and 4). Genotyping was 
not performed in 3 patients. Thirty-six patients (62.1%) received 
treatment: 17 achieved sustained viral response (SVR), 3 were non-
responders (all genotype 1 with compensated cirrhosis), treatment 
is ongoing in 13, 2 relapsed and treatment was ceased in 1 due to 
adverse events. Nineteen patients did not qualify for treatment 
(decompensated cirrhosis in 14) and 3 were lost to follow-up. 
Twenty-one of the 36 patients developed side-effects. 
Conclusion. HCV genotype 5 occurred exclusively in black patients. 
They responded well to therapy but, if untreated, followed the same 
natural history. Treatment was generally well tolerated with the 
most common side-effect being bone marrow suppression, which 
responded to dose adjustments and supportive therapy. 
An unusual cause of upper gastrointestinal bleeding
W Abuelhassan, R Ally
Gastroenterology Department, Chris Hani Baragwanath Academic Hospital
Introduction. Most of the causes of brisk upper gastrointestinal 
bleeding can be diagnosed during oesophagogastroduodenoscopy. 
However, the diagnostic dilemma ensues when no cause for the 
bleeding is readily obvious.
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Case presentation. A 45-year-old female patient with HIV infection 
(CD4 count of 445 cells/µl) presented to the emergency department 
with acute haematemesis. She was pale, haemodynamically stable with 
8 g/dl haemoglobin, had a normal coagulation profile and cholestasis 
on liver function tests (LFTs). Urgent endoscopy was performed, 
which was normal. During admission, the patient developed malaena 
and her haemoglobin dropped to 3.8 g/dl. Repeat endoscopy showed 
a normal oesophagus, stomach and duodenal cap. Upon touching 
the ampulla of Vater, a jet of blood spurted through the ampulla 
(haemobilia). Urgent angiography of the coeliac axis was performed 
and revealed multiple aneurysms of the hepatic, left gastric and left 
gastroduodenal arteries, which were subsequently embolised. A 
diagnosis of HIV vasculopathy was made. The patient remained well 
with no further bleeding in the ensuing period and was subsequently 
discharged with a referral for initiation of antiretroviral therapy. 
Discussion. Haemobilia is a relatively common under-diagnosed 
cause of upper gastrointestinal bleeding with considerable morbidity 
and mortality. Angiography can aid in depicting the source of active 
bleeding. Aneurysms associated with HIV vasculopathy have been 
described mainly in the cerebral and popliteal circulations, with few 
reports of mesenteric and portal circulation vasculopathy. Clues to 
diagnosis include the presence of multiple aneurysms on angiography 
in an HIV patient, and are often associated with deranged LFTs. 
Single institution experience with Zollinger-Ellison 
syndrome: Causes of death and survival pattern
S Alharethi, S R Thomson, P C Bornman
Groote Schuur Hospital, Cape Town
Background. Mortality in Zollinger-Ellison syndrome (ZES) is not 
clearly established. We report a mortality analysis in a tertiary 
institution cohort.
Patients and methods. Forty-eight consecutive ZES patients were 
managed at Groote Schuur Hospital between 1978 and 2012. Thirty-
five males (73%) and 13 females (27%) were diagnosed at a mean age 
of 40 years. Forty (83%) patients had sporadic disease and 8 (17%) 
had multiple endocrine neoplasia type-1 (MEN-1). 
Results. Nineteen patients with a mean follow-up of 10.4 years 
died during the study period; 4 had MEN-1-associated gastrinoma. 
Nine patients are still attending follow-up (mean 19.7 years). Twenty 
patients had variable follow-up with a mean of 8.5 years. Five 
deaths were related to ZES, 2 patients died from duodenal ulcer 
haemorrhage, 1 from post-operative septic complications following 
repeated surgery, 1 from tumour progression, and 14 deaths were 
unrelated to ZES.
Conclusion. ZES is compatible with long-term survival. The 
majority of deaths are unrelated to ZES. Death from tumour 
progression is rare. Patients undergoing recurrent surgery are at 
increased risk of complications-related death.
A single-institution experience of type-1 multiple 
endocrine neoplasia (MEN-1)-associated gastrinoma
S Alharethi, S R Thomson, P C Bornman
Groote Schuur Hospital, Cape Town
Background. Multiple endocrine neoplasia type-1 (MEN-1) is a rare 
autosomal dominant disease affecting parathyroids, pancreas and 
pituitary glands.
Patients and methods. We report a single-institution experience 
over a 32-year period of 8 patients with MEN-1 identified from 48 
patients with Zollinger-Ellison syndrome. The mean age at diagnosis 
was 38 years.
Results. Seven patients presented with ZES or its complications, 
while 1 patient presented with hypercalcaemia. The average delay from 
onset of symptoms to diagnosis of ZES/MEN-1 was 6.5 years. Prior to 
diagnosis, 8 patients had surgery for peptic ulcer complications and 2 
had parathyroidectomy. Prolactin was raised in 8 patients, abnormal 
pituitary/cella turcica was seen on computed tomography (CT) in 
6 patients and 1 patient had acromegaly. Five patients underwent 
post-diagnosis parathyroidectomy with immediate normalisation 
of calcium in 4 and repeat surgery required in 1 patient. After 
diagnosis, 3 patients had no further surgical intervention for ZES. 
One patient had total gastrectomy. One had distal pancreatectomy 
and total gastrectomy. The remaining 3 patients each had 2 debulking 
procedures for a variety of pancreatic neuroendocrine tumours. No 
clinical or biochemical cure was achieved in this cohort. The median 
survival time was 18 years. There were 4 patient deaths, and 3 patients 
were lost to follow-up. One patient is alive and well. 
Conclusion. This study confirmed that surgery does not cure 
MEN-1-associated ZES. Screening for MEN-1 is required in all ZES 
patients even in the absence of family history. Long-term survival is 
the rule; hence, follow-up to detect metachronous neuroendocrine 
tumours is important.
HLA-DQ genotype distribution in type 1 diabetes 
mellitus patients with concomitant coeliac disease
S F Bakker1, M E Tushuizen1, J B A Crusius2, S Simsek3, 
C J J Mulder1, B M E von Blomberg4
VU Medical Center, the Netherlands
Background and aims. The estimated prevalence of coeliac disease 
(CD) in patients with type 1 diabetes mellitus (T1DM) is 5%. CD and 
T1DM, both multifactorial diseases, are strongly clustered in families. 
In both, human leukocyte antigen (HLA) class II molecules HLA-
DQ2.5 (DQB1*02-DQA1-05) and DQ8 (DQB1*0302 - DQA1*0301) 
are key genetic risk factors. We aimed to investigate HLA-DQ 
distributions in patients diagnosed with both T1DM and CD. 
Associations were examined between HLA-DQ and age of clinical 
onset and autoimmune comorbidity.
Material and methods. Patients with T1DM and concomitant 
CD were recruited from 33 hospitals in the Netherlands. We 
retrospectively collected data at T1DM and CD diagnosis, and 
regarding comorbidity of autoimmune diseases. T1DM diagnosis 
was defined as an absolute requirement of insulin, while CD 
diagnosis was based on international criteria (European Society for 
Paediatric Gastroenterology, Hepatology and Nutrition). Genomic 
DNA obtained from peripheral blood was used for typing of HLA-
DQA1* and DQB1* alleles, performed with a combined single-
stranded conformation polymorphism (SSCP)/ heteroduplex method 
by semi-automated electrophoresis and gel-staining. Patients were 
divided into two groups, childhood-onset T1DM (before age 20 
years) and adult-onset T1DM, because childhood-onset is strongly 
associated with HLA haplotypes.
Results. The total cohort consisted of 61 patients diagnosed 
with T1DM and CD (67.2% female; mean age 39.8±19.8 years; 
T1DM and CD duration of 22.6±16.8 years and 8.3±10.4 years, 
respectively). All patients were unrelated and self-reported Dutch 
whites. Patients carried HLA-DQ2.5 in 80.3% (50.8% heterozygous 
and 29% homozygous). Only 6/61 (9.8%) patients were diagnosed 
with CD before T1D; 50% of them were HLA-DQ2.5 homozygous. 
In the childhood-onset T1DM group (n=38), mean age of T1DM 
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onset was significantly lower in HLA DQ-8 heterozygotes v. other 
genotypes (4.9 v. 8.0 years; p=0.04). 
Conclusions. In patients with T1DM and CD, an 80.3% prevalence 
of carriers of HLA-DQ2.5 was found. Interestingly, in the childhood-
onset T1DM  group, a younger age of T1DM onset is associated 
with heterozygous HLA-DQ8. No associations were found between 
HLA-DQ type and the prevalence of autoimmune comorbidity or 
CD onset.
Surgery for giant-giant gastric ulcers – the bedsore of the 
stomach: A report of 6 recent cases
H Becker
Department of Surgery, School of Medicine, Faculty of Health Sciences, University of 
Pretoria
Introduction. Patients with giant gastric ulcers (≥3 cm) are 
significantly older and have more aggressive disease, reflected by a 
higher incidence of bleeding, anorexia, weight loss and emergency 
admission (Raju GS et al., Am J Gastroenterol 1999;94:3478-3486). 
These patients need prolonged aggressive treatment, with excellent 
compliance. The author wishes to propose a further subgroup of 
giants ulcers that are ≥3 cm but also have a deep penetrating base 
into adjacent organs (crater), where the base of the crater is an organ, 
usually the pancreas, liver or porta hepatic.
Postulate. These giant-giant (bedsore) ulcers will not heal, but 
become chronic and complicated with treatment. A low threshold 
for early referral to surgery is necessary. If little improvement is seen 
after 3 months of adequate medical treatment, surgery is indicated.
Material and methods. Six patients underwent emergency 
operations for uncontrollable haemorrhage from large penetrating 
gastric ulcers between December 2011 and May 2012. All patients 
needed definitive gastric surgery to control haemorrhaging (subtotal 
gastrectomy/antrectomy, including the ulcer, with or without truncal 
vagotomy).
Conclusion. Patients with giant penetrating gastric ulcers need 
early referral for definitive surgery. A low threshold for referral is 
imperative.
Malignant biliary obstruction: Plastic v. metal stents for 
palliation of symptomatic jaundice
M Bernon, J M Shaw, J E J Krige, S Burmeister, G E Chinnery, 
P C Bornman
Surgical Gastroenterology Unit, Groote Schuur Hospital and Department of Surgery, 
Faculty of Health Sciences, University of Cape Town 
Background. Both plastic and self-expanding metal stents (SEMS) 
have been used to relieve jaundice in patients with advanced 
malignant biliary obstruction. This study compared the clinical 
efficacy of plastic v. metal biliary stents.
Materials and methods. In a prospective randomised controlled 
trial 37 patients with malignant common bile duct obstruction not 
amenable to curative resection were offered palliative stenting from 
November 2008 to March 2012 and were followed-up until death. We 
compared patient survival and stent patency rates.
Results. Seventeen patients received 10 Fr. plastic stents and 20 
patients received SEMS. Mean duration of hospital stay after stenting 
was 2 days (range 1 - 2). One patient in each group remained 
jaundiced despite adequate biliary drainage. Plastic stents blocked 
more frequently than SEMS (47.5% v. 10.0%; p=0.015). In the SEMS 
group, 3 patients required re-admission to hospital (total 31 days) 
and median survival was 116 days, compared with 5 re-admissions 
(total 54 days) and a median survival of 105 days in the plastic stent 
group. Preliminary cost analysis showed similar costs per patient in 
both groups.
Conclusion. Plastic 10 Fr. biliary stents block more frequently than 
SEMS, which have a better patency rate and are associated with fewer 
hospital re-admissions. Metal stents are cost-effective in palliating 
malignant biliary obstruction in a public sector hospital.
Autoimmune hepatitis at Chris Hani Baragwanath 
Academic Hospital
B Bobat, R Ally
Chris Hani Baragwanath Academic Hospital, Johannesburg
Background. Autoimmune hepatitis (AIH) is a chronic inflammatory 
liver disease of any age, evidenced by variable and fluctuating clinical 
features and serum auto-antibodies.
Aim. To report experience with AIH at Chris Hani Baragwanath 
Academic Hospital (CHBAH).
Methods. An audit was performed of 15 AIH cases identified after 
a review of 243 patients attending the liver clinic at CHBAH between 
2009 and 2012. Demographics, clinical, laboratory and histology data, 
auto-antibodies, derived clinical scores and therapy were reviewed.
Results. Mean age of the 15 patients (14 females, 1 male) was 33.3 
years (range 14 - 68 years); 50% of the cohort had significant disease, 
initial mean model for end-stage liver disease (MELD) score of 14.8 
(6 - 26). Mean initial bilirubin was 92.38, improving to 16.35 after 
treatment. Mean alanine transaminase (ALT) improved from 345.23 
to 45.85 IU/ml. Ten cases tested positive for antinuclear antibodies 
(ANA). Anti-smooth-muscle antibody (ASMA) testing was positive 
in a single case. No cases tested positive for antibodies to liver/kidney 
microsomes (ALKM). Eight liver biopsies were performed; 6 were 
typical. Treatment improved the Child-Pugh score to a mean of 6.2 
(range 5 - 10). Comorbid diseases were observed, including type 1 
diabetes in 2 patients and single cases of hyperthyroidism, interstitial 
lung disease, non-Hodgkin’s lymphoma and ulcerative colitis with 
primary sclerosing colangitis. Initial treatment included prednisone 
followed by azathioprine. Currently, 10 patients are still receiving 
low-dose prednisone.
Conclusions. AIH at CHBAH has a female predominance and 
mainly affects young adults; 50% are clinically ill at presentation. 
ANA testing was a good indicator of disease, while ASMA and ALKM 
testing were not; anti-liver cytosol (ALC) may be a better option. 
Liver biopsies proved to be typical. Most patients responded very well 
to immunosuppressive therapy. 
Endoscopic management of bile leaks after laparoscopic 
cholecystectomy
G E Chinnery, J E J Krige, P C Bornman, M M Bernon, S Alharethi, 
S Hofmeyr, S Burmeister, S Cullis, S R Thomson
Groote Schuur Hospital, Cape Town
Background. A bile leak is an infrequent but potentially serious 
complication after biliary surgery. The aim of this study was to assess 
the effectiveness of endoscopic management.
Methods. An endoscopic retrograde cholangiopancreatography 
(ERCP) database was retrospectively reviewed to identify all patients 
with bile leaks after laparoscopic cholecystectomy. 
Results. One hundred and thirteen patients (92 women, 21 men) 
of median age 47 years (range 22 - 82) with a bile leak were referred 
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at a median of 18.1 days (range 1 - 226) after surgery. Symptoms 
included pain (13; 11.5%), abnormal liver function tests (LFTs) (22; 
19.5%), bile leak (25; 22.1%), intra-abdominal collections (45; 39.8%) 
and sepsis (8; 7%). Twenty-nine patients (25.7%) were found to have 
a major bile duct injury without duct continuity, requiring surgery. 
Forty-four patients had a cystic duct (CD) leak, 26 had a CD leak and 
common bile duct (CBD) stones, and 14 patients had a CBD injury 
amenable to endoscopic stenting. In the 70 patients with CD leaks, 
24 underwent a sphincterotomy (including 8 stone extractions), 43 
had a sphincterotomy and stenting (including 18 stone extractions), 
1 patient had stenting only, while 2 with previous sphincterotomies 
required no further intervention. Of the 14 patients with CBD injuries 
treated endoscopically, 7 had a class D injury, 3 had a class E5 injury, 
3 had a class B injury and 1 had a biliary stricture. The 113 patients 
underwent a total of 269 ERCPs (mean 2.4; range 1 - 7). 
Conclusions. Bile leaks after laparoscopic cholecystectomy in 75% 
of patients were due to CD leaks (with or without retained stones) or 
lesser bile duct injuries; these were amenable to definitive endoscopic 
therapy.
Inflammatory bowel disease (IBD) in Soweto
N A I Chopdat, R Ally
Department of Health, Chris Hani Baragwanath Academic Hospital, Johannesburg
Background. IBD is an integrated group of disorders characterised 
by recurrent, destructive inflammation of the gastrointestinal tract. 
The most common forms include ulcerative colitis (UC) and Crohn’s 
disease (CD). Most studies arise from Western populations; few, if 
any, describe IBD in the South African black population. 
Aim. To establish a formal IBD clinic at Chris Hani Baragwanath 
Academic Hospital (CHBAH), we assessed the demographics, disease 
spectrum and treatment responses in a cohort of CHBAH patients. 
Methods. From January 2011 to March 2012 all patients with a 
confirmed diagnosis of IBD on histology, irrespective of original 
date of diagnosis, were recruited. Patient files were analysed and data 
collected.
Results. Thirty-five patients, including 20 females, were recruited; 
88.6% were black, 8.6% were white and 2.8% were Asian. IBD subtypes 
included UC (91.4%) and CD (8.6%). In the latter, only 2 patients were 
black and 1 was white. In the UC group, left-sided colitis comprised 
47%, pancolitis 44% and distal colitis 9%. The most common extra 
intestinal manifestation was primary sclerosing cholangitis, followed 
by arthropathy. No patient had skin or eye involvement. The mainstay 
of treatment included salazopyrin, corticosteroids and azathioprine. 
No patient was on 6-mercaptopurine (6MP) or biologicals. Three 
patients were defined as having steroid-dependent CD (too small for 
further analysis).
Conclusion. IBD is common in our Soweto community. A high 
index of suspicion is needed for the diagnosis of more cases. 
Specialised clinics and registries are needed to improve patient 
outcome and quality of life.
Case summary: The neuroendocrine tumour effect
N A I Chopdat, R Ally
Department of Health, Chris Hani Baragwanath Academic Hospital, Johannesburg
History. We report a case of a 53-year-old male patient who presented 
with syncope and haematemesis in a second presentation after 
almost 1 year. Gastroduodenoscopy 1 year preceding was reported as 
normal. No other previous background history was notable.
Examination and findings. The patient appeared well, apart from 
postural hypotension and sinus tachycardia. His haemoglobin 
was 14.5 g/dl and coagulation profile was normal. At 22h00 he 
complicated and had massive haematemesis necessitating intensive 
care unit (ICU) admission. The patient was resuscitated and received 
a proton pump inhibitor (PPI) infusion. Emergency endoscopy 
revealed blood in the stomach, making visualisation difficult. 
Endoscopic haemostasis was achieved with epinephrine injections 
blindly at the site thought to be bleeding. Repeat endoscopy revealed 
a reddish mass lesion along the lesser curvature of the stomach, 
with active bleeding, resulting in emergency surgery. At surgery, a 
well-delineated mass was found with histology consistent with a well-
differentiated neuroendocrine tumour (NET) that extends into the 
muscularis. Gastrin and chromogranin A were normal. A diagnosis 
of a type 3 NET was made. Octreoscan showed no evidence of distant 
disease. He was referred to oncology and completed chemotherapy. 
He has had an excellent outcome so far.
Discussion. Although rare, NET must be considered as a cause 
of haematemesis. Various diagnostic tools including specific urine 
and serum markers may help to identify a specific tumour type 
Tumour localisation and metastasis is performed via endoscopy, 
radiological imaging and somastatin receptor scintigraphy. Treatment 
modalities include surgery, somastatin analogues, chemotherapy and 
radiotherapy.
HIV/AIDS cholangiopathy, biochemical, histological 
and cholangiographic features in a South African cohort
N A I Chopdat, R Ally
Department of Health, Chris Hani Baragwanath Academic Hospital, Johannesburg
Background. HIV-associated cholangiopathy is considered rare – a 
form of biliary inflammation characterised by abnormal cholestatic 
liver enzymes and biliary duct irregularities. The aetiology remains 
unclear. Opportunistic infections are implicated. 
Objectives. To describe the biochemical, cholangiographic and 
histological findings in HIV-positive patients with abnormal 
cholestatic liver enzymes.
Methods. In a pilot study, data were collected from our Liver 
Clinic. HIV patients with elevated cholestatic enzymes (>2 times the 
upper limit of normal for alkaline phosphatase (ALP) and gamma 
glutamyl transferase (GGT)), but without viral, drug, autoimmune 
hepatitis or diabetes or high level of alcohol consumption were 
recruited. All patients underwent an ultrasound to exclude 
obstructive aetiologies. Endoscopic retrograde/magnetic resonance 
cholangiopancreatography (ERCP)/(MRCP) and liver biopsy was 
performed in selected cases.
Results. From December 2011 to March 2012, 19 patients (including 
10 men) were recruited. Abdominal pain (n=12) was the most 
common manifestation; the remaining patients were asymptomatic. 
Mean ALP and GGT were 720 U/l and 1 127 U/l, respectively. The 
mean CD4 lymphocyte count was 120 cells/mm3. Only 3 patients 
were on highly active antiretroviral therapy (HAART) at presentation. 
Ultrasonography was abnormal in only 3 patients (dilated common 
bile duct); 63% underwent ERCP, with the major finding being paucity 
of the peripheral bile ducts (58%). The most common finding on liver 
histology was granulomatous hepatitis (32%). Mycobacterium was the 
most common opportunistic infection.
Conclusion. HIV-associated cholangiopathy is not uncommon 
in the SA HIV population. ERCP is an important diagnostic and 
therapeutic modality. Liver histology is a powerful diagnostic tool for 
opportunistic infections.
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Clinical, laboratory and outcome data of hepatocellular 
carcinoma in Mozambique
L Cunha, N B Bhatt, P Modcoicar, F Lorenzo, F Mbofana, 
F Fernandes, E Samo Gudo, N Macie, B Meggi, C Maueia, 
C Carrilho, I V Jani
Hospital Central de Maputo, Mozambique
Background. Hepatocellular carcinoma (HCC) is a lethal cancer and 
represents the fifth most common malignancy in the world. Data 
on clinical and laboratory characteristics and prevalence of hepatitis 
virus infection among HCC patients in Mozambique are scarce. We 
aimed to investigate these parameters in HCC patients attending 
Maputo Central Hospital (Hospital Central de Maputo) (HCM).
Methods. Between March 2011 and April 2012, 105 patients with 
HCC attending HCM, were enrolled and screened for hepatitis B 
virus (HBV), hepatitis C virus (HCV) and HIV. Alpha-fetoprotein 
levels, abdominal ultrasound and fine needle aspiration (FNA) for 
cytology were performed routinely. Clinical and demographic data 
were collected using a standard questionnaire. 
Results. HCC was most frequent in men (72.4%) and mean patient 
age was 49.7±15.7 years. Lower educational level, history of smoking 
and alcohol intake were found in 69%, 5.7% and 58% of patients, 
respectively. The prevalence of HBV, HCV and HIV infection was 
52.9%, 4.9% and 11.9%, respectively. HBV/HIV co-infection was 
found in 9% of patients. No patient was co-infected with HBV/HCV 
or HCV/HIV. Alpha-fetoprotein was >400 UI in 62.7% of patients. 
Multinodular presentation in the liver was detected by ultrasound in 
80%. Mean survival was 66.5±6.7 days.
Conclusions. Overall, our data demonstrated that chronic HBV 
infection is highly prevalent in Mozambican HCC patients, suggesting 
that HBV represents the major cause of HCC. The poor survival rate 
may reflect the advanced stage of tumours at the time of diagnosis.
Colorectal cancer in Ugandan patients: A morphological 
study
D N Dijxhoorn, A Boutall, C J Mulder, A Mall, R Ssebuufu, 
S Kalungi, C Baigrie, P A Goldberg
Introduction. Colorectal cancer (CRC) is uncommon in Africa. 
Inherited cancers may account for a greater portion of the disease 
burden in low- v. high-incidence areas. CRC-related demographics 
and histological features and the incidence of hereditary nonpolyposis 
colorectal cancer (HNPCC) in African populations are largely 
unknown.
Aim. To assess the demographic and morphological features of 
CRC patients from hospitals in Mulago and Mbarara, Uganda.
Methods. Histopathological specimens of 81 Ugandan CRC 
patients (2006 - 2010) were retrospectively reviewed. Demographic 
data were retrieved from medical records. Tumours were examined 
to determine histological features suggestive of mismatch repair 
gene mutations (according to the revised Bethesda guidelines for 
microsatellite instability testing). 
Results. The median CRC patient age was 55 years (range 20 - 89) at 
diagnosis; 30.6% and 6.9% were aged <50 and <30 years, respectively. 
Tumours were mostly (94.9%) located in the left side of the colon. 
Mucinous adenocarcinoma was significantly more common in 
patients aged <50 years. Based on the histological and demographic 
features, 22/81 (27.3%) patients met at least 1 criterion of the revised 
Bethesda Guidelines for MSI testing.
Conclusions. Histological and demographic features suggestive of 
HNPCC were identified in 27.3% of patients. These features appear 
to be quite different from published data from First-World countries. 
The lack of endoscopic equipment in Uganda may account for the 
majority of cancers being left-sided.
MRCP and ERCP demonstration of biliary tract disease
M Lagaud, Z Ghoor, O Mzileni, A Elnagar
Dr George Mukhari Hospital, Department of Health, Gauteng
Introduction. Hepatobiliary diseases are often effectively diagnosed 
by abnormal liver biochemical tests and ultrasonography. However, 
there are also unusual cases that may require additional diagnostic 
procedures such as magnetic resonance cholangiopancreatography 
(MRCP) and endoscopic retrograde cholangiopancreatography 
(ERCP). Clinical features often do not present the true extent of the 
disease, especially in patients with AIDS-related cholangiopathy. This 
presentation reports a case of biliary disease diagnosed and managed 
by MRCP and ERCP.
Case description. A 23-year-old female who had used highly 
active antiretroviral therapy (HAART) and anti-tuberculosis drugs, 
presented with jaundice, fever and dry cough. Clinical examination 
and liver enzymes tests were suggestive of hepatobiliary disease. 
The patient’s alanine transaminase (ALT) was 48 IU/l, aspartate 
transaminase (AST) was 559 U/l, AST-platelets-rate-index was 
6.1, alkaline phosphatase (ALP) was 209 U/l and gamma-glutamyl 
transpeptidase (GGT) was 38 U/l. In addition, cytomegalovirus 
(CMV) DNA analysis by polymerase chain reaction (PCR) revealed 
584 000 copies/ml, with a CD4 cell count of 125 cells/mm3 and CMV 
pneumonitis. Ultrasonography showed only acalculous cholecystitis 
(ACC) with pericholecystitis fluid; also seen with MRCP. ERCP 
revealed sclerosing cholangitis in a setting of vanishing bile duct 
syndrome (VBDS), ulcerated stenotic duodenal papillitis and ACC.
Discussion. MRCP and ERCP performed equally well. MRCP 
should be used to screen AIDS patients, irrespective of the pattern of 
the liver enzymes abnormalities. MRCP also helps to select appropriate 
patients for ERCP, which will be required to obtain tissue samples for 
microbiological studies and for sphincterotomy (if needed).
Repeat endoscopic rapid urease test as a surrogate 
marker for the success of Helicobacter pylori eradication
D Levin, P Williams, S R Thomson
PAWC and Groote Schuur Hospital, Cape Town
Background. Amoxil and metronidazole are first-line antimicrobial 
eradication therapy for Helicobacter pylori infection at Groote Schuur 
Hospital. Metronidazole resistance is purported to be high. There are 
no local data assessing the efficacy of this strategy. 
Methods. We evaluated the efficacy of antimicrobial therapy in 
patients with H. pylori infection, in patients with a positive rapid 
urease test (RUT) at initial endoscopy and who underwent a 
repeat endoscopy and RUT. Data analysed included those from a 
prospective endoscopy database that were merged with the antibiotic 
regimen dispensed from our pharmacy database. A positive RUT 
at index and a negative RUT at repeat endoscopy were considered 
successful eradication. 
Results. Over a 48-month period, 270 patients positive for H. 
pylori infection at index endoscopy underwent a repeat endoscopy 
and repeat RUT; 132 patients had a positive RUT at index, but 
negative RUT at repeat endoscopy; H. pylori was considered to be 
successfully eradicated in 132/270 (49%). One hundred and thirty-
eight patients were positive for H. pylori infection at both index and 
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repeat endoscopy. Seventy-four patients received antibiotic therapy at 
the index endoscopy, from our pharmacy. Sixty-four of 138 (46.4%) 
patients did not receive treatment from our pharmacy at index 
endoscopy. After excluding those who did not receive therapy, the 
failure rate for H. pylori eradication was 74/206 (36%).
Conclusions. This selected sample revealed an H. pylori eradication 
rate of 36%, far below the standard efficacy rate of <10%. The study 
also identified a possible prescription-dispensing problem that may 
have contributed to the high eradication failure rate. 
A clinicopathological spectrum of anal cancer in 
Kwazulu-Natal
T E Madiba, X H Ntombela
University of KwaZulu-Natal
Aim. To document our experience with the management of anal 
cancer presenting to the KwaZulu-Natal teaching hospitals.
Methods. We analysed prospectively collected data on anal 
cancer patients from 2004 to 2011, including demographics, clinical 
presentation, tumour site, treatment, outcome and follow-up.
Results. One hundred and thirty patients were included in the 
study (M:F ratio, 1:1, mean age, 51±14.0 years). Presenting symptoms 
were anal mass (41), bleeding (27), ulcer (24), loss of weight and/
or appetite (19), anal pain (18), peri-anal abscess/fistula (16), 
change in bowel habit (14), warts (8), and incontinence (6). Mean 
duration of symptoms was 15.37±19.41 months. Histology confirmed 
squamous carcinoma in 95, adenocarcinoma in 33, melanoma in 
1 and neuroendocrine tumour in 1. There were 104 anal margin 
tumours and 26 anal canal tumours. Ten patients (8%) had distant 
metastases at diagnosis. Ten patients (8%) were eligible for surgery. 
The remainder were managed non-operatively. Seventy-nine patients 
were lost to follow-up and the rest were followed up for 1 - 69 months 
(mean 16±17.0 months). Eleven patients have been confirmed to 
have died so far.
Conclusion. Anal cancer affects all population groups with an 
equal incidence in both sexes. Squamous carcinoma was 3 times as 
common as adenocarcinoma. Anal margin tumours were 5 times as 
common as anal canal tumours. Delayed clinical diagnosis leads to 
poor prognosis. 
Metastatic colorectal cancer in KwaZulu-Natal: A 12-year 
experience
T E Madiba, R Naidoo
University of KwaZulu-Natal
Background. The liver is the most common site of colorectal 
metastases, followed by the lungs. 
Aim. To evaluate our experience with the clinical presentation, 
management and outcome of metastatic colorectal cancer (CRC). 
Methods. We analysed data from a prospectively compiled 
CRC database (2000 - 2011), pertaining to demographics, clinical 
presentation, disease staging, treatment, outcome and follow-up.
Results. Of 1 424 CRC patients, 245 (17%) had metastatic CRC 
(mean age 57.5±14.6 years; 1:1 male:female ratio). Primary sites were 
ascending colon and caecum (31), hepatic flexure (7), transverse (9), 
splenic flexure (4) descending (8), sigmoid colon (150), rectum (122). 
Sites of metastases were liver (172; 70%), lung (47; 19%), peritoneum 
(21; 9%), omentum (12; 5%), ovaries (8; 3%) and miscellaneous 
(9). Ninety-five patients (39%) underwent resection of the primary 
tumour. Two hundred and twenty-five patients (92%) presented 
for oncology treatment and follow-up, while 60 patients refused, 
absconded or were too ill for oncological treatment. Excision of liver 
and lung metastasis was performed in 1 patient each. Mean follow-
up was 15±17.3 months. Overall, 58 patients died (24%); 2 following 
resection and 56 due to disease progression.
Conclusion. Metastatic colorectal carcinoma accounts for 17% 
of CRC in KwaZulu-Natal. The liver is the most common site. The 
surgical intervention rate is extremely low in our setting. Patient 
follow-up remains a problem. Not surprisingly, there is an appreciable 
mortality.
Predictors for new bleeding in patients with higher 
digestive haemorrhage due to portal hypertension in 
Maputo Central Hospital, Mozambique 
P Modcoicar, L Cunha, J Arteaga
Service of Gastroenterology, Hospital Central de Maputo, Mozambique
Objective. Variceal rebleeding frequently develops after acute variceal 
bleeding and is the most life-threatening complication in patients 
with cirrhosis. We aimed to ascertain the predictive factors of new 
episodes of bleeding due to rupture of oesophageal varices (EHV) 
and first episodes of bleeding after placement of elastic bandages in 
patients suffering from portal hypertension (PHT).
Methods. In 2011 we analysed 436 consecutive patients, presenting 
between 2003 and 2009, with endoscopically proved degree III 
and IV varices at the Endoscopy Unit of Maputo Central Hospital 
(Hospital Central de Maputo) (HCM). Two-hundred and thirteen 
patients were diagnosed with higher digestive haemorrhage at 
admission (first arm) and 223 with PHT (second arm) underwent 
endoscopic variceal band ligation. 
Results. In the first arm, 28 (13.1%) patients rebled; 19 (68.0%) 
rebled after 6 weeks. In the second arm, 15 (6.7%) patients bled; in 
12 (80.0%) this occurred after 6 weeks. Using multivariate analysis, 
irregular follow-up (OR 4.0, 95% confidence interval (CI) 1.7 - 9.2, 
p<0.001) and pancytopenia (2.99, 95% CI 1.33 - 6.73, p<0.01) were, 
independently, predictors of rebleeding in the first arm. In the 
second arm, irregular follow-up (4.2, 95% CI, 1,4 - 12.4, p<0.004), 
pancytopenia (OR 4.2, 95% CI, 1.32 - 12.4, p<0.009) and anaemia at 
admission (OR 10.5, 95% CI, 1.6 - 68.5, p<0.003) were, independently, 
predictors of bleeding.
Conclusions. Irregular follow-up and pancytopenia in both arms, 
and anaemia in the second arm, are predictors of new episodes of 
bleeding in our setting.
A case of collagenous gastritis in an 18-year-old black 
female from Zambia
I Moola, A Mahomed
Charlotte Maxeke Johannesburg Academic Hospital
Case report. An 18-year-old black Zambian female residing in 
Johannesburg presented with vomiting, fatigue and malaise. Aside 
from pallor, her physical examination was normal. Her full blood 
count showed hypochromic microcytic anaemia. Her haemoglobin 
(Hb) was 4.7 g/dl, MCV (mean corpuscular volume) was 68.8 fl, and 
white cell count and platelet counts were normal. Further investigation 
showed severe iron deficiency anaemia with 1.1 µmol/l (9.0 - 30.4) 
serum iron, 2 µg/l (5 - 148) ferritin and 1% percentage saturation. 
Vitamin B12 and red cell folate levels were normal. Gastroscopy 
showed an extensive pangastritis with nodular infiltrate most marked 
in the fundus and corpus of the stomach. The nodules were 4 - 8 mm 
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in diameter. No active bleeding, erosions or ulceration was noted. The 
duodenum and oesophagus were normal macroscopically. Biopsy 
of the affected lesions showed severe chronic gastritis with severe 
activity, with evidence of erosions, focal ulceration and atrophy with 
focally prominent submucosal fibrosis. No intestinal metaplasia, 
dysplasia or malignancy was noted. Helicobacter pylori infection was 
not observed. The differential diagnosis was collagenous gastritis 
and auto-immune gastritis. Other differentials were scleroderma and 
post-radiation therapy changes. Extensive physical and biochemical 
investigation revealed no other abnormalities. Follow-up colonoscopy 
showed a normal-looking mucosa with no features of collagenous 
colitis. A diagnosis of collagenous gastritis was made. Follow-up 
gastroscopy after 1 year of oral 20 mg omeprazole daily showed 
similar endoscopic appearance. The iron deficiency was treated with 
intravenous iron and the patient’s full blood count normalised. She is 
currently asymptomatic.
Outcome of cricopharyngomyotomy and diverticulopexy 
for Zenker’s diverticulum
P Nel, H van der Walt
Objectives. To determine the outcomes after long-term follow-up 
of patients who underwent Zenker’s diverticulum repair using only 
cricopharyngomyotomy with diverticulopexy.
Methods. This is an observational descriptive study. Only patients 
with proven Zenker’s diverticulum who underwent cricopharyngeal 
myotomy and diverticulopexy were included in the study. Patients 
with recurrences were included.
Results. Fifty-four cases were included; subject age ranged from 30 
to 89 years with no sex predominance. Mean follow-up was 6 months. 
The main complaint was dysphagia and regurgitation. All patients 
improved with a cricopharyngomyotomy and diverticulopexy. There 
were 4 major complications and 1 recurrence.
Conclusion. Cricopharyngomyotomy and diverticulopexy for 
Zenker’s diverticulum is a safe procedure for all patients, with very 
good outcome and long-term results.
An unusual cause of cholestasis: IgG4-associated 
sclerosing cholangiopathy
N Parsoo, V G Naidoo, K A Newton
Inkosi Albert Luthuli Hospital and Department of Health, KwaZulu-Natal 
Introduction. Autoimmune pancreatitis and IgG4-associated 
cholangitis are recently recognised pancreaticobiliary manifestations 
of IgG4-associated systemic disease. It may mimic pancreatic cancer, 
primary sclerosing cholangitis or cholangiocarcinoma.
Case presentation. A 68-year-old male presented with a 1-year 
history of steatorrhoea, weight loss and a 2-week history of jaundice 
with pruritus. The patient had no history of alcohol consumption. 
Clinical examination revealed jaundice and a firm 3 cm hepatomegaly. 
Biochemical testing showed cholestasis. An ultrasound demonstrated 
prominent intrahepatic ducts and dilated common bile duct; however, 
no obstructing lesion could be visualised. A magnetic resonance 
cholangiopancreatogram (MRCP) showed multiple strictures 
involving the intrahepatic ducts. Primary sclerosing cholangitis 
(PSC) was the most likely consideration. Colonoscopy was normal. 
Endoscopic ultrasound (EUS) revealed a thickened common bile duct 
wall of 3.3 mm. Fine-needle aspiration of an indistinct hypoechoic 
pancreatic head mass showed lymphocytes with no evidence of 
malignancy. The IgG4 subset was elevated to 10 times the upper limit 
of normal. A diagnosis of IgG4 sclerosing cholangiopathy was made 
and the patient was commenced on prednisone therapy. There was 
remarkable improvement in the liver function tests and pruritus after 
2 weeks of steroids. Repeat endoscopic ultrasound showed reduction 
in common bile duct wall thickness to 2.0 mm.
Conclusion. IgG4-associated sclerosing cholangiopathy should 
be considered in suspected PSC as it responds well to steroids. The 
use of EUS to evaluate bile duct wall thickness and for subsequent 
monitoring of therapeutic response is not well described and may 
be of value.
Geographic distribution of gastroscopy referrals to a 
tertiary unit: Implications for the development of an 
equitable endoscopy service
A Rajula, S R Thomson, G Watermeyer
Groote Schuur Hospital and the University of Cape Town
Background. Gastroscopy is not yet a tertiary hospital procedure. 
Groote Schuur Hospital (GSH) provides 80% of the gastroscopy 
service for the Cape Metro West Health Area (CMWHA), with the 
remainder provided by Somerset Hospital (SH), G F Jooste Hospital 
(GFJH), and Victoria Hospital (VH). To plan a comprehensive 
equitable gastroscopy service, the geographical distribution of 
referrals needs to be mapped. 
Methods. From 1 September to 31 October all gastroscopy records 
entered into a prospective database at the gastrointestinal unit of 
GSH added home location to the dataset. Locations were allocated 
according to the catchment areas/proximity of the 4 CMWHA 
hospitals – and whether patients’ home locations fell within the 
catchment areas or not.
Results. Gastroscopies performed annually included 6 300 at GSH, 
1  439 at VH, 1 141 at SH and 0 at GFJH. Of the 482 endoscopies 
performed during the 2-month study period, 80 had no recorded 
address. Sixteen per cent of the patients were not from CMWHA, 
while 49%, 10% and 3% should have gone to GFJH, VH and SH, 
respectively. Only 22% of the patients were located within GSH’s true 
catchment area.
Conclusion. The gross inadequacy of a secondary-level gastroscopy 
service is highlighted. There is an urgent need to establish an 
endoscopy service at GFJH and to ensure that the services in the 
adjacent districts are responsible for their own patients. 
Revisional laparoscopic surgery for failed laparoscopic 
Nissen fundoplication: A private practice experience
M Z Shaik, B Govender, A D R Reddy, P Rajaruthnam
Background. The efficacy of revisional surgery in failed laparoscopic 
Nissen fundoplications (LNFs) (failed due to recurrent reflux and/or 
new symptoms following a successful period of antireflux surgery) is 
promising in current literature. This is an audit of our practice. 
Methods. Nine cases of revision of failed LNFs were carried out 
over a 3-year period at a private surgical practice and analysed by 
retrospective chart review. Two cases were failed redo LNFs.
Results. Symptoms before re-operation were dysphagia (n=5), 
heartburn (n=4) and persistent epigastric pain (n=3). Endoscopic 
findings included reflux oesophagitis (n=2), hiatal hernia (n=2), 
stenoses (n=1) and no abnormality (n=4). Barium swallows showed 
reflux (n=3), wrap herniation (n=1), contrast hold-up (n=1), ‘cup 
and spill’ deformity (n=1), oesophageal dysmotility (n=1) and no 
abnormality (n=1). Mechanisms of failure at re-operation were 
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cruraplasty stenosis (n=5), tight wrap (n=1), wrap herniation 
(n=1), wrap disruption (n=2), slipped wrap (n=1). Intra-operative 
oesophageal and stomach injuries were limited to patients with 
previous redo operations (n=2); these were repaired laparoscopically. 
Wraps and cruraplasties were undone only (n=5) in tight wraps and 
stenosed cruraplasties. Redo LNFs (n=4) were performed in slipped, 
herniated and disrupted wraps. Follow-up at 1, 3, and 12 months 
revealed overall patient satisfaction and relief of symptoms (n=7) 
with persistent dysphagia in 1 patient. 
Conclusion. Revisional laparoscopic surgery is safe and offers 
effective symptom relief for failed LNFs. The risk of iatrogenic injury 
increases with subsequent redo fundoplications.
Diarrhoea in Schnitzler syndrome
W Simmonds, O C Buchel, R C Flooks, V J Louw
Universitas Hospital and Department of Health, Bloemfontein, Free State
Background. Schnitzler syndrome is a rare idiopathic condition 
characterised by recurrent episodes of non-pruritic urticarial 
rash, fever, bone pain, arthralgia or arthritis, and a monoclonal 
gammopathy (IgM or more rarely, IgG) in concentrations <10 g/l. 
According to the literature, approximately 100 cases of Schnitzler 
syndrome have been reported to date. 
Case description. We report a case of Schnitzler syndrome affecting 
a 54-year-old male who, in addition, had diarrhoea with his episodes 
of urticaria. No other cause for diarrhoea was found on further 
evaluation. We postulate that the diarrhoea may be caused by excess 
interleukin-1 activity, thought to be a primary mediator in Schnitzler 
syndrome. Ciprofloxacin and loratadine therapy was initiated in the 
patient, with good effect.  
Conclusion. Diarrhoea in Schnitzler syndrome has not previously 
been documented. The probable role of interleukin-1 as the cause for 
the diarrhoea requires confirmation.
Initial experience with HROPT subtype classification of 
achalasia: A potential tool to predict outcome
J E C Botha, S Hlatshwayo, S R Thomson, P C Bornman, 
G Watermeyer
Gastrointestinal Unit, Groote Schuur Hospital and the University of Cape Town
Background. High-resolution oesophageal pressure topography 
(HROPT) details pressure topography of the oesophagus, and an 
integrated relaxation pressure (IRP) for the lower oesophageal 
sphincter complex which allows subtyping. This study describes the 
3 achalasia subtypes in our patient population and the early outcome 
of different therapies. 
Methods. Over 14 months patients diagnosed with achalasia on 
clinical, barium swallow and endoscopy features underwent HROPT 
and were categorised into the 3 subtypes: I – classic achalasia, 
failed peristalsis; II – achalasia with compression, pan-oesophageal 
pressurisation; III – achalasia with rapid propagated pressurisation 
spasm. Treatment was at the individual clinician’s discretion.
Results. Eighteen patients had primary achalasia. Average age was 
42 years (range 11 - 77). The frequency of the subtypes was as follows: 
I – 5; II – 12; III – 1. The mean lower oesophageal sphincter pressure 
(LOSP) of 37 mmHg was highest in subtype II. Female patients were 
3 times more common in type II. IRP increased from subtype I to 
III. Nine patients had pneumatic balloon dilatation (PBD), 4 had 
a Hellers myotomy, and 1 is awaiting surgery. Four patients were 
treated elsewhere. Eight have had a good initial result. Two patients 
had a repeat PBD. Two patients have not yet been evaluated post-
operatively. One patient has not returned for clinical assessment, and 
1 patient died from a PBD perforation.
Conclusion. Our early experience with HROTP clearly identifies 
subsets of patients with achalasia, which are indistinguishable on 
standard clinical and investigational grounds. There is a predominance 
of subtype II. Greater accrual and long-term follow-up are required to 
evaluate if these subtypes predict durable outcome. 
HOMECOMING
You have come this far - 
keep moving … don’t turn back. 
No one holds the measure 
of their own undoing … no one,
the meaning of their dying. 
Hold what lives 
behind the masks 
of your own making …
the music of your wild name. 
Know that every tumble, 
every turn on your twisting path 
is a dance within a living 
church of elements, 
a sanctuary of stars
wings, breath and bone  
where the masks of your making 
are undone.  
From ‘Untamed’ 
Ian McCallum  soitgoes@iafrica.com 
